Matthew McLennan 5.0 7 ideas

Becton Dickinson (BDX) is a world leader in syringes and catheters with over 50% market share, giving it scale economies, embeddedness in hospital systems, and a regenerative feedback loop for innovation. It trades at 12-13 times earnings (8% earnings yield), implying the market expects little growth, yet the company is focused, generates strong free cash flow, and uses it for dividends and buybacks. It is well-positioned to benefit from the growth of biologics and integration of technology like AI.

The market is over 70% concentrated in the US and heavily concentrated in tech stocks, which increases risk. While some tech stocks are attractive, taking too much risk on a single country or sector is dangerous. Instead, investors should seek variegation and intentional non-uniformity to build resilience, avoiding overconcentration in US equities and tech.

Hoshizaki is the world leader in commercial ice machines, with a strong reputation, scale, and embedded position in restaurants and hotels. It trades at 8-9 times EBITDA, well below its competitor Rational (20 times) and typical LBO valuations. Management is a good steward, focusing on capital allocation through dividends, buybacks, and bolt-on acquisitions, making it an 'eclectic royalty' with a durable market position.

Gold is a positional asset with a fixed supply, acting as a store of value and ballast in a portfolio. It is inert, scarce, and globally mobile, making it a defensive hedge against uncertainty and currency debasement. Over time, its value accretes with nominal wealth, but the risk/reward is now more symmetric after its recent run-up, so the position is managed with a valuation margin of safety.

Cash provides ballast and optionality to deploy in market downturns. The amount held is limited to what can be realistically deployed in a crisis, so the return includes not just the yield but the option value of buying great businesses at attractive prices during weakness.